NCT00719615 is a clinical trial in Thyroid Cancer, sponsored by University of Nebraska.

Who is sponsoring NCT00719615?

NCT00719615 is sponsored by University of Nebraska.

What condition does NCT00719615 study?

NCT00719615 studies Thyroid Cancer.

Is NCT00719615 still recruiting?

NCT00719615 is currently completed. Last updated 16 October 2023.

Are results published for NCT00719615?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-10-16 · How we verify

NCT00719615

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assess Vitamin D Levels in Those With & Without Thyroid Cancer

Completed Results posted Last updated 16 October 2023

What this trial tests

trial in Thyroid Cancer in 111 participants. Completed in 1 June 2009.

Timeline

28 May 2008

Primary endpoint
1 March 2009

1 June 2009

Quick facts

Lead sponsor	University of Nebraska
Status	Completed
Study type	OBSERVATIONAL
Enrollment	111
Start date	28 May 2008
Primary completion	1 March 2009
Estimated completion	1 June 2009
Sites	1 location across United States

Conditions studied

Thyroid Cancer — all drugs for Thyroid Cancer →

Sponsor

University of Nebraska

Who can join

19 and older, any sex, with Thyroid Cancer. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Persons That Are Vitamin D Deficient in the Thyroid Nodule, Thyroid Cancer in Remission, and the Active Thyroid Cancer Groups. Primary · Within 12 months of enrollment in thyroid cancer collaborative registry (TCCR) database

We evaluated serum calcium,creatinine,albumin,and 25-hydroxyvitaminD(25-OH-D)in 42 thyroid nodule, 45 thyroid cancer in remission, \& 24 active thyroid cancer patients. We also determined the number and percent of participants in each group that had vitamin D deficiency, defined as 25-OH-D \< 30 ng/ml.

Group	Value	95% CI
Thyroid Nodules	23
Thyroid Cancer in Remission	20
Active Thyroid Cancer	11

Sponsor's own description

The purpose of this study is to evaluate Vitamin D levels in thyroid cancer patients with active disease compared with thyroid cancer patients in remission and patients with thyroid nodules.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Natural compounds as anticancer agents: Experimental evidence.
Wang J, Jiang YF. · · 2012 · cited 56× · PMID 24520533 · DOI 10.5493/wjem.v2.i3.45

Verify or expand the search:

Other recruiting trials for Thyroid Cancer

Currently open trials in the same condition.

NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting
NCT07370675 — Active Surveillance for Bethesda IV Thyroid Nodules · NA · recruiting
NCT07389512 — Pharmaceutical Management in Targeted Radioligand Therapy · recruiting
NCT07438847 — 177Lu-CTR-FAPI for the Treatment of Thyroid Cancer · Phase 1 · recruiting
NCT07419932 — Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer · recruiting

Other University of Nebraska trials

Trials by the same sponsor.

NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00719615 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
Last refreshed: 16 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00719615.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing